EndorTech

Company Overview

Snapshot

Founded in June 2023 by Ronen Sasson, EndorTech operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing a patented disruptive mechanism for pain relief.

Business overview

EndorTech is a Health Tech & Life Sciences company focused on revolutionizing pain management. The company develops a patented aerosol technology that delivers commercial quantities of synthetic beta-Endorphin, a neuropeptide, as a natural alternative to opioid pain killers. This innovative approach aims to provide rapid pain relief by directly targeting discomfort without the side effects associated with traditional methods, serving the pharmaceuticals and drug delivery markets.

Company Intelligence Q&A

What is EndorTech's core product or technology?

EndorTech has developed a patented disruptive mechanism utilizing pure synthetic aerosolized beta-Endorphin. This cutting-edge aerosol technology allows for the inhalation of endorphins, providing rapid pain relief by directly targeting the source of discomfort.

When was EndorTech founded and by whom?

EndorTech was founded in June 2023 by Ronen Sasson, who serves as Co-founder & CEO.

What problem does EndorTech aim to solve?

EndorTech aims to provide a natural alternative to current opioid pain killers by delivering synthetic biological beta-Endorphin, which offers pain relief without side effects and at a competitive price, intending to render older methods obsolete.

What are the primary sectors and markets EndorTech operates in?

EndorTech operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development. The company targets the healthcare market, including patients, with its pain relief solutions.

What is the current stage of EndorTech's product development?

EndorTech's products, including EndoRelief, EndoRecover, and EndoElevate, are currently in the Beta stage of development.